The Department of Defense (DOD) is seeking innovative solutions through the Small Business Innovation Research (SBIR) program to develop prophylactics and therapeutics for neurotoxin exposure, specifically targeting organophosphorus compounds used in chemical warfare. The objective is to create a biological agent that can prevent illness from exposure to G-type and V-type nerve agents, with a focus on stability, efficacy, and pharmacokinetics for both prophylactic and therapeutic applications. This initiative is crucial for enhancing the safety of military personnel on the battlefield and protecting civilians from potential chemical attacks. Interested parties should note that the solicitation will open on January 29, 2025, and close on February 26, 2025, with further details available at the DOD SBIR website.